EPISODE · Dec 11, 2020 · 9 MIN
MPR Weekly Dose #61 - Sitagliptin findings in pediatrics; Obesity treatment gains expanded approval; The FDA issue a CRL; And a new transdermal contraceptive
from MPR Weekly Dose
This week we cover new findings for the diabetes drug sitagliptin in pediatrics; An obesity treatment has approval expanded; The FDA issue a Complete Response Letter for an outpatient alternative treatment; And news of availability for a transdermal contraceptive patch.
Embed this episode
Ready to play
MPR Weekly Dose #61 - Sitagliptin findings in pediatrics; Obesity treatment gains expanded approval; The FDA issue a CRL; And a new transdermal contraceptive
0:00
9:30
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MPR Weekly Dose?
This episode is 9 minutes long.
When was this MPR Weekly Dose episode published?
This episode was published on December 11, 2020.
Can I download this MPR Weekly Dose episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!